Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 160

1.

Chlamyweb Study II: a randomised controlled trial (RCT) of an online offer of home-based <i>Chlamydia trachomatis</i> sampling in France.

Kersaudy-Rahib D, Lydié N, Leroy C, March L, Bébéar C, Arwidson P, de Barbeyrac B.

Sex Transm Infect. 2017 May;93(3):188-195. doi: 10.1136/sextrans-2015-052510. Epub 2017 Apr 4.

PMID:
28377422
2.

Screening for Chlamydia trachomatis Infections in Women.

Wiesenfeld HC.

N Engl J Med. 2017 Feb 23;376(8):765-773. doi: 10.1056/NEJMcp1412935. Review. No abstract available.

PMID:
28225683
3.

Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States.

Ditkowsky J, Shah KH, Hammerschlag MR, Kohlhoff S, Smith-Norowitz TA.

BMC Infect Dis. 2017 Feb 18;17(1):155. doi: 10.1186/s12879-017-2248-5.

4.

The Ballseye programme: a mixed-methods programme of research in traditional sexual health and alternative community settings to improve the sexual health of men in the UK.

Estcourt C, Sutcliffe L, Mercer CH, Copas A, Saunders J, Roberts TE, Fuller SS, Jackson LJ, Sutton AJ, White PJ, Birger R, Rait G, Johnson A, Hart G, Muniina P, Cassell J.

Southampton (UK): NIHR Journals Library; 2016 Dec.

5.

Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women.

Rours GI, Smith-Norowitz TA, Ditkowsky J, Hammerschlag MR, Verkooyen RP, de Groot R, Verbrugh HA, Postma MJ.

Pathog Glob Health. 2016 Oct - Dec;110(7-8):292-302.

PMID:
27958189
6.

Budgetary Impact of Compliance With STI Screening Guidelines in Persons Living With HIV.

Eaton EF, Hudak K, Muzny CA.

J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):303-308. doi: 10.1097/QAI.0000000000001212.

PMID:
27787348
7.

Young People's Views and Experiences of a Mobile Phone Texting Intervention to Promote Safer Sex Behavior.

French RS, McCarthy O, Baraitser P, Wellings K, Bailey JV, Free C.

JMIR Mhealth Uhealth. 2016 Apr 15;4(2):e26. doi: 10.2196/mhealth.4302.

8.

The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial.

Smith KS, Kaldor JM, Hocking JS, Jamil MS, McNulty AM, Read P, Bradshaw CS, Chen MY, Fairley CK, Wand H, Worthington K, Blake S, Knight V, Rawlinson W, Saville M, Tabrizi SN, Garland SM, Donovan B, Guy R.

BMC Public Health. 2016 Jan 28;16:83. doi: 10.1186/s12889-016-2727-4.

9.

What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion.

Dukers-Muijrers NH, Schachter J, van Liere GA, Wolffs PF, Hoebe CJ.

BMC Infect Dis. 2015 Nov 17;15:533. doi: 10.1186/s12879-015-1280-6.

10.
11.

Diagnostic accuracy of rapid tests for sexually transmitted infections in symptomatic women.

Nuñez-Forero L, Moyano-Ariza L, Gaitán-Duarte H, Ángel-Müller E, Ruiz-Parra A, González P, Rodríguez A, Tolosa JE.

Sex Transm Infect. 2016 Feb;92(1):24-8. doi: 10.1136/sextrans-2014-051891. Epub 2015 Jul 1.

PMID:
26136508
12.

Cost-effectiveness of Chlamydia vaccination programs for young women.

Owusu-Edusei K Jr, Chesson HW, Gift TL, Brunham RC, Bolan G.

Emerg Infect Dis. 2015 Jun;21(6):960-8. doi: 10.3201/eid2106.141270.

13.

Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures.

Trebach JD, Chaulk CP, Page KR, Tuddenham S, Ghanem KG.

Sex Transm Dis. 2015 May;42(5):233-9. doi: 10.1097/OLQ.0000000000000248.

14.

Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in The Netherlands.

de Wit GA, Over EA, Schmid BV, van Bergen JE, van den Broek IV, van der Sande MA, Welte R, Op de Coul EL, Kretzschmar ME.

Sex Transm Infect. 2015 Sep;91(6):423-9. doi: 10.1136/sextrans-2014-051677. Epub 2015 Mar 10.

PMID:
25759475
15.

Impact and cost-effectiveness of chlamydia testing in Scotland: a mathematical modelling study.

Looker KJ, Wallace LA, Turner KM.

Theor Biol Med Model. 2015 Jan 15;12:2. doi: 10.1186/1742-4682-12-2.

16.

Heterogeneity in risk of pelvic inflammatory diseases after chlamydia infection: a population-based study in Manitoba, Canada.

Davies B, Ward H, Leung S, Turner KM, Garnett GP, Blanchard JF, Yu BN.

J Infect Dis. 2014 Dec 1;210 Suppl 2:S549-55. doi: 10.1093/infdis/jiu483.

17.

Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program.

Frost JJ, Sonfield A, Zolna MR, Finer LB.

Milbank Q. 2014 Dec;92(4):696-749. doi: 10.1111/1468-0009.12080. Epub 2014 Oct 15.

18.

Feasibility of Chlamydia trachomatis screening and treatment in pregnant women in Lima, Peru: a prospective study in two large urban hospitals.

Cabeza J, García PJ, Segura E, García P, Escudero F, La Rosa S, León S, Klausner JD.

Sex Transm Infect. 2015 Feb;91(1):7-10. doi: 10.1136/sextrans-2014-051531. Epub 2014 Aug 8.

19.

Comparison of two Gram stain point-of-care systems for urogenital gonorrhoea among high-risk patients: diagnostic accuracy and cost-effectiveness before and after changing the screening algorithm at an STI clinic in Amsterdam.

Bartelsman M, Straetemans M, Vaughan K, Alba S, van Rooijen MS, Faber WR, de Vries HJ.

Sex Transm Infect. 2014 Aug;90(5):358-62. doi: 10.1136/sextrans-2013-051500. Epub 2014 May 23.

PMID:
24860102
20.

Rationale and design of REACT: a randomised controlled trial assessing the effectiveness of home-collection to increase chlamydia retesting and detect repeat positive tests.

Smith KS, Hocking JS, Chen M, Fairley CK, McNulty A, Read P, Bradshaw CS, Tabrizi SN, Wand H, Saville M, Rawlinson W, Garland SM, Donovan B, Kaldor JM, Guy R.

BMC Infect Dis. 2014 Apr 24;14:223. doi: 10.1186/1471-2334-14-223.

Supplemental Content

Loading ...
Support Center